Investing Profile

Vasudev Bailey

General Partner at ARTIS Ventures

av.co/vasudev-baileySan Francisco, California

Your Intro Paths to Vasudev Bailey

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Vasudev Bailey on

Current Investing Position

Artis Ventures (AV) General Partner

Investment Range

$250K - $25.0M

Sweet Spot

$10.0M

Investments On Record

Vasudev Bailey is on these Sector & Stage Rankings

BioTech (Seed)BioTech (Series A)Health IT (Series A)San Francisco Bay Area Health IT (Seed)

Vasudev Bailey's Investments On Record (11)

Company	StageDateRound Size	Total Raised
Eko Health	Series DJun 2024$41M Series CNov 2020$65M Series BSep 2019$20M Series AMar 2018$5M	$140M
Co-investors: Pieter Kemps (Peak XV Partners (formerly Sequoia Capital India & SEA)), Stephen Hays (What If Ventures), Rob Toews (Radical Ventures), Corey Mulloy (Highland Capital Partners), Ryan Drant (Questa Capital), Jeremy Fiance (The House Fund), Charles Seely (Hoxton Ventures), Michael Baum
OverT Bio	SeedMay 2024$16M	$16M
Co-investors: Sara Choi (Wing Venture Capital)
Freenome	Series UnknownFeb 2024$250M Series DDec 2021$300M Series BJul 2019$160M	$1.1B
Co-investors: Amir Nashat (Polaris Partners), Peter Kolchinsky (RA Capital), Jeffrey Schwartz (Bain Capital Life Sciences), Bill Maris (Section 32), Skip Fleshman (Asset Management Ventures), Daniel Coley (Cofounders Capital), Anne Wojcicki
Unnatural Products	Series ADec 2023$32M SeedSep 2019$6M	$38M
Co-investors: Prem Tumkosit (Merck Global Health Innovation Fund), Ameena El-Bibany (Artis Ventures (AV))
Ozlo Sleep	Series AAug 2023$10M	$10M
ONI	Series BDec 2021$75M	$75M
Co-investors: Keith Crandell (ARCH Venture Partners), David Schwab (Vertical Venture Partners), Paul Conley (Paladin Capital Group), Mike Pellini (Section 32)
Delix Therapeutics	Series ASep 2021$70M	$70M
Co-investors: Ken Belotsky (Negev Capital), Andrew Levin (RA Capital), Matias Serebrinsky (PsyMed Ventures)
Excision BioTherapeutics	Series AFeb 2021$60M SeedSep 2017$10M	$81M
Co-investors: Chris Sklarin (Alumni Ventures ), Anton Simunovic (Alumni Ventures ), Brian Keil (Alumni Ventures ), Andre De Baubigny (Modern Venture Partners), Ben Kong (Rebel Fund), Lawrence Jen (Anderson Angels), Daniel Rothman